MoneyWorks4Me

Lupin - Quaterly Results

07 Nov 2024 Evaluate
The Revenue for the quarter ended  September 2024 of Rs. 41062.00 millions grew by 12.21 % from Rs. 36592.30 millions.Good  Net Profit growth of 47.24% reported above the corresponding previous quarter figure of Rs. 5486.10 millions to Rs. 8077.60 millioins.Operating Profit saw a handsome growth to 11473.70 millions from 8608.40 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 41062.00 36592.30 12.21 82738.30 71548.70 15.64 146665.00 112588.30 30.27
Other Income 326.20 256.00 27.42 717.00 533.40 34.42 1067.30 912.60 16.95
PBIDT 11473.70 8608.40 33.28 23852.60 15936.00 49.68 35657.90 11739.20 203.75
Interest 175.50 153.20 14.56 311.00 315.00 -1.27 563.50 984.40 -42.76
PBDT 11298.20 8455.20 33.62 23541.60 15621.00 50.70 35094.40 10754.80 226.31
Depreciation 1457.70 1494.80 -2.48 2871.90 2895.30 -0.81 7247.50 5483.40 32.17
PBT 9840.50 6960.40 41.38 20669.70 12725.70 62.42 27846.90 5271.40 428.26
TAX 1762.90 1474.30 19.58 3700.30 2470.00 49.81 4586.00 1019.30 349.92
Deferred Tax 43.40 177.70 -75.58 88.90 166.20 -46.51 -254.50 60.40 -521.36
PAT 8077.60 5486.10 47.24 16969.40 10255.70 65.46 23260.90 4252.10 447.04
Equity 912.30 910.50 0.20 912.30 910.50 0.20 911.40 910.00 0.15
PBIDTM(%) 27.94 23.53 18.78 28.83 22.27 29.44 24.31 10.43 133.18
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..